NL-OMON43320招募中不适用
Aortic Replacement using Individualised Regenerative Allografts: Bridging the Therapeutic Gap - ARISE
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- corlife oHG
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 64（—）
入选标准
- •1. Indication for aortic valve replacement according to current medical guidelines in valvular heart disease.
- •2. Informed consent of legal guardians or patients, assent of patients.
排除标准
- •1. The patient has not provided surveillance informed consent.
- •2. The patient shall not suffer from
- •a. generalized connective tissue disorders (e.g. Marfan syndrome), or
- •b. active rheumatic disorders, or
- •c. severe asymmetric calcification of the valve ring.
- •3. The coronary arteries of the patient shall not be in abnormal position or heavily calcified.
- •4. Patients shall not show hypersensitivity against sodium dodecyl sulphate (SDS), sodium desoxycholate (SDC), human collagen (or other elastic fibers) or Benzonase®.
研究者
相似试验
已完成
不适用
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")Heart Valve DiseaseNCT02527629corlife144
招募中
不适用
Aortic valve reconstruction with autologous pericardium for patients with small aortic annulussevere aortic valve diseaseJPRN-UMIN000035804Shimane University Faculty of Medicine10
招募中
3 期
A novel aortic valve reconstruction with autologous pericardium for aortic valve diseaseAortic valve stenosis and/or regurgitationJPRN-UMIN000011193Deparment of General and Cardiothoracic Surgery, Graduate School of Medicine, Gifu University10
招募中
不适用
Surgical Replacement and Transcatheter Aortic Valve Implantation Trial 10 Year Follow-upsevere aortic valve stenosis10046973NL-OMON45149Medtronic B.V.160
终止
不适用
REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk SubjectsAortic Valve StenosisNCT03618095Boston Scientific Corporation382